Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.97
-0.05 (-0.91%)
Apr 23, 2026, 4:00 PM EDT - Market closed
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.46 billion as of April 23, 2026. Its market cap has increased by 34.89% in one year.
Market Cap
1.46B
Enterprise Value
1.42B
1-Year Change
34.89%
Ranking
Category
Stock Price
$5.97
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.46B, an increase of 502.76%. That is a compound annual growth rate of 16.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 1.46B | 3.19% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.55B |
| AnaptysBio | 1.54B |
| Nanobiotix | 1.54B |
| Immunocore Holdings | 1.52B |
| Immatics | 1.51B |
| Corvus Pharmaceuticals | 1.50B |
| Viridian Therapeutics | 1.48B |
| Iovance Biotherapeutics | 1.45B |